Preliminary determination of a molecular basis to chronic fatigue syndrome

Biochemical and Molecular Medicine

Volumn 57, Issue 2, 1996, Pages 73-80

  Mcgregor, Neil R ^a   Dunstan, R Hugh ^b   Zerbes, Mariann ^b   Butt, Henry L ^c   Roberts, Timothy K ^b   Klineberg, Iven J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c JOHN HUNTER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITIC ACID; ALANINE; BETA ALANINE; GLUTAMIC ACID; SUCCINIC ACID; TYROSINE;

ADULT; AMINO ACID URINE LEVEL; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; MULTIVARIATE ANALYSIS; URINALYSIS;

EID: 0029968859     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1996.0012     Document Type: Article

References (31)

1. Holmes GP, Kaplan JE, Gantz NM et al. Chronic fatigue syndrome: A working case definition. Ann Intern Med 108:387-389, 1988.
2. Sharpe MC, Archard LC, Banatvala JE et al. A report-Chronic fatigue syndrome: guidelines for research. J R Soc Med 84:118-121, 1991.
3. Fukuda K, Straus SE, Hickie I et al. Chronic Fatigue Syndrome: A comprehensive approach to its definition and study. Ann Intern Med 21:953-959, 1994.
4. Suhadolnik RJ, Reichenbach NL, Hitzges P et al. Upregulation of the 2-5A Synthetase/RNase L pathway associated with chronic fatigue syndrome. Clin Infect Dis 18:S96-S104, 1994.
5. 12U), in chronic fatigue syndrome. Clin Infect Dis 18:S88-S95, 1994.
6. Levy JA. Viral studies of chronic fatigue syndrome. Clin Infect Dis 18:8117-8120, 1994.
7. Demitrack MA, Dale JK, Straus SE et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 73:1224-1234, 1991.
8. Demitrack MA, Gold PW, Dale JK, Krahn DD, Kling MA, Straus SE. Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: Preliminary findings. Biol Psychiatry 32:1065-1077, 1992.
9. McCain GA, Tilbe KS. Diurnal hormonal variation in fibromyalgia syndrome: A comparison with rheumatoid arthritis. J Rheumatol 16:154-157, 1989.
10. Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Wall K. Serum amino acids in fibrositis/fibromyalgia syndrome. J Rheumatol 16:158-163, 1989.
11. Derogatis LR. SCL-90-R administration, scoring and procedures manual - II for the revised version and other instruments of the psychopathology rating scale series. Towson, MD: Clinical Psychometrics Research, 1975.
12. MacKenzie SL, Tenaschuk D. Quantitative formation of N(O,S)-heptofluorobutyryl isobutyl amino acids for GC analysis. I. Esterification. J Chromatogr 171:195-208, 1979.
13. MacKenzie SL, Tenaschuk D. Quantitative formation of N(O,S)-heptofluorobutyryl isobutyl amino acids for GC analysis. II. Acylation. J Chromatogr 173:13-63, 1979.
14. Walsh K, Dunstan RH, Murdoch RN. Differential bioaccumulation of heavy metals and organopollutants in the soft tissue and shell of the marine gastropod, Austrocochlea constricta. Arch Environ Contamination Toxicol 28:35-39, 1995.
15. Rudman D. Protein-energy undernutrition. In Principles of Internal Medicine (Isselbacher KJ, Adams RD, Braunwald E, Pertersdorf RG, Wilson JD, Eds.), 9th ed. New York: McGraw-Hill, 1980, pp 407-411.
16. Hyde BM, Goldstein J, Levine P. The Clinical and Scientific Basis of Myalgic Enceplialomyelitis/Chronic Fatigue Syndrome. Ogdensburg, New York: The Nightingale Foundation, 1992.
17. Briggs NC, Levine PH. A comparison of systemic and neurological symptomatology in outbreaks collectively described as chronic fatigue syndrome, epidemic neuromyasthenia, and myalgic encephalomyelitis. Clin Infect Dis 18:S32-S42, 1994.
18. Keith RA, Mangano TJ, Meiners BA et al. HA-966 acts at a modulatory glycine site to inhibit N-methyl-D-aspartate-evoked neurotransmitter release. Eur J Pharmacol 166: 393-400, 1989.
19. Reynolds IJ, Harris KM, Miller RJ. NMDA receptor antagonists that bind to the strychnine-insensitive glycine site and inhibit NMDA-induced Ca2+ fluxes and [3H]GABA release. Eur J Pharmacol 172:9-17, 1989.
20. Regunathan S, Missala K, Sourkes TL. Central regulation of adrenal tyrosine hydroxylase: Effect of induction on catecholamine levels in the adrenal medulla and plasma. J Neurochem 53:1706-1710, 1989.
21. Morrow BA, Clark WA, Roth RH. Stress activation of mesocorticolimbic dopamine neurons: Effects of a glycine/NMDA receptor antagonist. Eur J Pharmacol 238:255-262, 1993.
22. Wu FS, Gibbs TT, Farb DH. Dual activation of GABAA and glycine receptors by beta-alanine: Inverse modulation by progesterone and 5 alpha-pregnan-3-alpha-ol-20-one. Eur J Pharmacol 246:239-246, 1993.
23. Kent Braun JA, Sharma KR, Weiner MW, Massie B, Miller RG. Central basis of muscle fatigue in chronic fatigue syndrome. Neurology 43:125-131, 1993.
24. Trisch D, Mawlawi H, Biellmann JF. Mechanism-based inhibition of pro line dehydrogenase by pro line analogues. Biochim Biophys Acta 1202:77-81, 1993.
25. Jones ME. Conversion of glutamate to ornithine and proline: pyrroline-5-carboxylate, a possible modulator of arginine requirements. J Nutr 115:509-515, 1985.
26. Snyder R. Ethyl Browning's Toxicity and Metabolism of Industrial Solvents, 2nd ed., Vol II: Nitrogen and Phosphorous Solvents. Amsterdam: Elsevier, 1990.
27. Sax NI. Dangerous Properties of Industrial Materials, 6th ed. New York: Van Nostrand-Reinhold, 1984.
28. Carricaburi P, Lacroix R, Lacroix J. Modifications of the white mouse electroretinogram after injection of organic solvents. Ann Pharm Fr 38:155, 1980.
29. Baggio G, Ferrari F, Farrari P. Adrenaline release caused by N-methylpyrrolidone injected into the adrenal gland. Farmaco, ED Prat 31:275-282, 1976.
30. Scriver CR, Nutzenadel W, Perry TL. Disorders of β-alanine and carnosine metabolism. In The Metabolic Basis of Inherited Disease, 4th ed, (Stanbury JB, Wyngaarden JB, Frederickson DS, Eds.), New York: McGraw-Hill Book, 1978, pp 528-542.
31. Rosenblatt S, Clowes GH, George BC, Hirsch E, Lindberg B. Exchange of amino acids by muscle and liver in sepsis. Arch Surg 118:167-175, 1983.